China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

China Resources Sanjiu (CR Sanjiu) is a leading state-owned pharmaceutical company in China, operating as a core subsidiary of the China Resources Group. The company is a dominant force in the Over-the-Counter (OTC) and Traditional Chinese Medicine (TCM) markets, famously known for its '999' brand. It specializes in the research, development, and manufacturing of consumer healthcare products and prescription drugs across various therapeutic areas including respiratory, digestive, dermatological, and cardiovascular health. In recent years, CR Sanjiu has transitioned from a traditional TCM manufacturer to an innovation-driven healthcare giant. Through aggressive M&A activity, including the landmark acquisitions of Kunming Pharmaceutical Group and Tasly Pharmaceutical Group, the company has significantly expanded its footprint in the 'silver economy' (elderly care) and innovative prescription drug pipelines. It currently operates over 11 production bases and maintains a massive retail presence with thousands of partner pharmacies across China.